0

    530233

    AUROLAB

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    AURO LABORATORIES LTD. Share Price Today

    Investment Returns

    Over 1 Month -3.00% Over 3 Months -4.11% Over 6 Months 7.75% Over 1 Year 0.35%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    AURO LABORATORIES LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 158.90
    • P/E Ratio (TTM) 44.97
    • Beta 0.91
    • Book Value / share 74.37
    • Return on equity 4.33%
    • EPS (TTM) 5.84
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.97
    info icon alternate text

    AURO LABORATORIES LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 9.83
    Operating Expense 8.90
    Net Profit 0.97
    Net Profit Margin (%) 9.86
    Earnings Per Share (EPS) 1.56
    EBITDA 3.85
    Effective Tax Rate (%) 32.87
    Particulars DEC 2025 (Values in Cr)
    Revenue 9.39
    Operating Expense 7.83
    Net Profit 1.95
    Net Profit Margin (%) 20.76
    Earnings Per Share (EPS) 3.13
    EBITDA 4.24
    Effective Tax Rate (%) -12.06
    Particulars SEP 2025 (Values in Cr)
    Revenue 8.84
    Operating Expense 8.09
    Net Profit 0.72
    Net Profit Margin (%) 8.14
    Earnings Per Share (EPS) 1.15
    EBITDA 3.32
    Effective Tax Rate (%) 58.13
    Particulars JUN 2025 (Values in Cr)
    Revenue 2.77
    Operating Expense 3.30
    Net Profit -0.11
    Net Profit Margin (%) -3.97
    Earnings Per Share (EPS) -0.17
    EBITDA 0.44
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 7.40
    Operating Expense 7.17
    Net Profit 0.39
    Net Profit Margin (%) 5.27
    Earnings Per Share (EPS) 0.63
    EBITDA 0.94
    Effective Tax Rate (%) -11.42
    Particulars MAR 2026 (Values in Cr)
    Revenue 30.74
    Operating Expense 27.79
    Net Profit 3.53
    Net Profit Margin (%) 11.48
    Earnings Per Share (EPS) 5.67
    EBITDA 11.87
    Effective Tax Rate (%) 26.61
    Particulars MAR 2025 (Values in Cr)
    Revenue 19.40
    Operating Expense 18.17
    Net Profit 1.84
    Net Profit Margin (%) 9.48
    Earnings Per Share (EPS) 2.95
    EBITDA 4.06
    Effective Tax Rate (%) 2.12
    Particulars MAR 2024 (Values in Cr)
    Revenue 53.64
    Operating Expense 44.80
    Net Profit 7.79
    Net Profit Margin (%) 14.52
    Earnings Per Share (EPS) 12.50
    EBITDA 12.18
    Effective Tax Rate (%) 24.63
    Particulars MAR 2023 (Values in Cr)
    Revenue 52.89
    Operating Expense 50.39
    Net Profit 2.44
    Net Profit Margin (%) 4.61
    Earnings Per Share (EPS) 3.92
    EBITDA 5.33
    Effective Tax Rate (%) 28.98
    Particulars MAR 2022 (Values in Cr)
    Revenue 50.87
    Operating Expense 48.08
    Net Profit 2.84
    Net Profit Margin (%) 5.58
    Earnings Per Share (EPS) 4.56
    EBITDA 5.72
    Effective Tax Rate (%) 26.61
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 68.94
    ROE % 4.33
    ROCE % 3.79
    Total Debt to Total Equity 0.81
    EBITDA Margin 20.93
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 67.32
    ROE % 20.46
    ROCE % 20.37
    Total Debt to Total Equity 0.43
    EBITDA Margin 22.71
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 54.87
    ROE % 7.43
    ROCE % 9.89
    Total Debt to Total Equity 0.31
    EBITDA Margin 10.08
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 50.58
    ROE % 9.45
    ROCE % 12.20
    Total Debt to Total Equity 0.28
    EBITDA Margin 11.24
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 45.86
    ROE % 28.67
    ROCE % 38.90
    Total Debt to Total Equity 0.13
    EBITDA Margin 22.12
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.62
    Total Assets 99.09
    Total Liabilities 99.09
    Total Equity 42.96
    Share Outstanding 0
    Price to Book Ratio 3.34
    Return on Assets (%) 1.85
    Return on Capital (%) 2.15
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.64
    Total Assets 85.73
    Total Liabilities 85.73
    Total Equity 41.95
    Share Outstanding 0
    Price to Book Ratio 2.39
    Return on Assets (%) 9.08
    Return on Capital (%) 11.42
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 2.41
    Total Assets 55.99
    Total Liabilities 55.99
    Total Equity 34.20
    Share Outstanding 0
    Price to Book Ratio 1.00
    Return on Assets (%) 4.36
    Return on Capital (%) 6.01
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 12.39
    Total Assets 54.96
    Total Liabilities 54.96
    Total Equity 31.52
    Share Outstanding 0
    Price to Book Ratio 1.98
    Return on Assets (%) 5.17
    Return on Capital (%) 6.28
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 14.53
    Total Assets 41.89
    Total Liabilities 41.89
    Total Equity 28.58
    Share Outstanding 0
    Price to Book Ratio 1.77
    Return on Assets (%) 17.13
    Return on Capital (%) 22.7
    Particulars MAR 2025 (Values in Cr)
    Net Income 1.88
    Cash from Operations 5.74
    Cash from Investing -24.45
    Cash from Financing 17.68
    Net change in Cash -1.01
    Free Cash Flow 29.54
    Particulars MAR 2024 (Values in Cr)
    Net Income 10.34
    Cash from Operations 18.80
    Cash from Investing -38.67
    Cash from Financing 19.09
    Net change in Cash -0.76
    Free Cash Flow 54.44
    Particulars MAR 2023 (Values in Cr)
    Net Income 3.44
    Cash from Operations 3.28
    Cash from Investing -5.08
    Cash from Financing -8.17
    Net change in Cash -9.97
    Free Cash Flow 7.35
    Particulars MAR 2022 (Values in Cr)
    Net Income 3.87
    Cash from Operations -6.59
    Cash from Investing -5.34
    Cash from Financing 9.79
    Net change in Cash -2.14
    Free Cash Flow -1.98
    Particulars MAR 2021 (Values in Cr)
    Net Income 10.50
    Cash from Operations 12.81
    Cash from Investing -3.50
    Cash from Financing -0.45
    Net change in Cash 8.85
    Free Cash Flow 13.19
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 13.52 1.58 250.74 23.12 38.85
    BLISS GVS PHARMA LTD 506.15 40.69 4.49 5368.04 118.35 552.90
    CIPLA LTD. 1458.45 30.95 3.42 117820.20 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 345.85 15.26 2.50 1017.87 256.40 399.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 22.88 4.21 250.74 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 536.85 24.06 4.19 1552.07 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8297.90 108.37 23.76 20744.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 506.15 54.72 4.64 5368.04 118.35 552.90

    AURO LABORATORIES LTD. shareholding pattern

    Holding
    47.81%
    52.17%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    AURO LABORATORIES LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    255.00 0.31 redarrow
    red-green-graph indicator
    13 Bearish
    3 Bullish
    • 5 Days 255.00
    • 26 Days 257.90
    • 10 Days 255.50
    • 50 Days 260.20
    • 12 Days 255.80
    • 100 Days 260.10
    • 20 Days 257.10
    • 200 Days 255.10
    255.27 PIVOT
    First Support 251.53 First Resistance 257.93 Second Support 248.87 Second Resistance 261.67 Third Support 245.13 Third Resistance 264.33
    RSI 46.76 ADX 26.02 MACD -2.17 Williams % R -72.13 Commodity Channel Index (CCI) -48.69
    Date 2026-07-03 Week 3291.00 Same Day 989.00 Month 2928.00
    1 Year 0.92 3 Year 0.63
    Over 1 Month
    -3.00% down
    Over 1 Year
    0.35% down
    Over 3 Months
    -4.11% down
    Over 3 Years
    46.27% down
    Over 6 Months
    7.75% down
    Over 5 Years
    7.10% down

    AURO LABORATORIES LTD. Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Auro Laboratories Ltd?

    Answer Field

    Auro Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 255.00 as on Jul 03 2026 03:27 PM.

    What is the Market Cap of Auro Laboratories Ltd Share?

    Answer Field

    The market cap of Auro Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 158.90 as on Jul 03 2026 03:27 PM.

    What is the 52 Week High and Low of Auro Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Auro Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 317.00 and ₹ 159.00.

    What is 1 year return for Auro Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been 0.35%.

    What is the P/E Ratio of Auro Laboratories Ltd Share?

    Answer Field

    As on Jul 03 2026 03:27 PM the price-to-earnings (PE) ratio for Auro Laboratories Ltd share is 44.97.

    What is the PB ratio of Auro Laboratories Ltd Share?

    Answer Field

    As on Jul 03 2026 03:27 PM, the price-to-book (PB) ratio for Auro Laboratories Ltd share is 74.37.

    How to Buy Auro Laboratories Ltd Share?

    Answer Field

    You can trade in Auro Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Auro Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Auro Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Auro Laboratories Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |